Skip to main navigation Skip to search Skip to main content

ModernaTX: Phase 2 Two-Part Study (Open-Label [Part 1] Followed by Observer-Blind/Randomize Part 2 to Evaluate Safety Tolerability Reactogenicity & Effectiveness of mRNA 1273.214 SARS-CoV-2 Vaccine in Participants Aged 12 Weeks to 6 Months

Project: Research

Project Details

StatusFinished
Effective start/end date03/9/23 → 07/18/26

Funding

  • PPD Investigator Services LLC: $24,820.00